The Lundbeck Foundation delivers record-breaking result

The Lundbeck Foundation, which is the majority stakeholder in pharmaceutical firm Lundbeck, has had its best year to date, ending 2021 with a profit of DKK 6.9bn (USD 1bn).
Photo: Gregers Tycho/ERH
Photo: Gregers Tycho/ERH
by Benjamin Werner Christensen, translated by daniel pedersen

The very affluent majority owner of pharmaceutical firm Lundbeck, the Lundbeck Foundation, has just announced a historically good year, according to the foundation’s annual report for 2021.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading